Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

Starting in the new year, Independence Blue Cross, the region’s largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when they’re prescribed solely for weight loss.

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...

Novo Nordisk, the maker of perhaps the most sought-after prescription drugs in the world, says Ozempic and Wegovy are now being shipped regularly to wholesalers. After a year where products were ...

Two clinical trials investigating semaglutide (Ozempic, Wegovy) as an early Alzheimer's treatment are expected to wrap up in ...

Kathy Bates, Oprah, Ashley Benson and more celebs who've talked about semaglutide drugs including Ozempic and Wegovy — and where they fall on its usage Kate Hogan is Director of Digital Specials ...

A new study has found that semaglutide, the active ingredient in the popular weight loss drugs Ozempic and Wegovy, may be linked to a type of sudden vision loss called non-arteritic anterior ...

Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...

The drugs, which include blockbuster medications like Ozempic and Wegovy, have helped millions of Americans quickly shed excess pounds. About 1 in 8 U.S. adults say they've taken one.

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...